Results for this period
Full year1 June 2025–31 May 2026ConsolidatedJapanese GAAPThe width of the band at each stage is based on revenue. The narrower it becomes toward the bottom, the smaller the proportion of revenue that remains as profit. The dotted outline is the full-year forecast and the band inside it is the result for this period. The progress rate is the result divided by the forecast.
塗りつぶした部分が自己資本比率です。総資産のうち、返済のいらない自前の資金がどれだけかを表します。The thin vertical line indicates the level at the end of the previous fiscal year.
Stacked from zero: upward is an increase in cash, downward a decrease (in ¥ million).The net change represented by the dotted line is the total of three items, calculated from figures provided by the company.
Revenue growth was driven by detergents, solid fuels and infection-control products. The increase in profit in the Chemicals business resulted from product sales, pricing and cost reductions, while labor and logistics costs weighed on profit. The Healthcare business reported lower revenue and profit due to declines in overseas and domestic product sales.
Not applicable.
| Item | Details |
|---|---|
| Fiscal Period Classification | Full year |
| Accounting standards | Japanese GAAP |
| Consolidated / non-consolidated | Consolidated |
| Period Covered | 1 June 2025–31 May 2026 |
| Net Sales | ¥24,619 million (YoY +3.8%) |
| Operating profit | ¥2,118 million (YoY +10.1%) |
| Ordinary income | ¥2,217 million (YoY +13.5%) |
| Profit attributable to owners of the parent | ¥1,900 million (YoY +5.3%) |
| Net income per share | ¥321.01 |
| Operating Margin | 8.6％ |
| Equity ratio | End of the current fiscal period 68.2％ / End of previous period 65.3％ |
| Total assets | ¥23,840 million |
| Net assets | ¥16,268 million |
| Cash flows from operating activities | ¥2,704 million |
| Cash flows from investing activities | ¥39 million |
| Cash flows from financing activities | ¥-1,376 million |
| Cash and cash equivalents at end of period | ¥7,888 million |
| Full-year earnings forecast | Net Sales ¥27,500 million (YoY +11.7%) / Operating profit ¥1,800 million (YoY -15.0%) / Ordinary income ¥1,850 million (YoY -16.6%) / Profit attributable to owners of the parent ¥1,285 million (YoY -32.4%) |
| Annual Dividend Forecast | ¥92 → ¥84 |
| Payout ratio | Fiscal year ending May 2026 24 ％ / Fiscal year ending May 2027 (forecast) 37.8 ％ |
| Shareholder Return Policy | Dividend on equity (DOE) of at least 3% |
| Segment revenue | ¥23,267 million (YoY +4.7%), ¥1,351 million (YoY -9.0%) |
| Segment profit | ¥1,906 million (YoY +15.7%), ¥212 million (YoY -23.6%) |
| Depreciation and amortization | ¥530,602 thousand |
| Impairment loss | ¥0 thousand |
| Breakdown of extraordinary income (loss) | Extraordinary income Gain on sale of investment securities ¥418,844 thousand, Gain on sale of non-current assets ¥1,000 thousand, Gain on sale of shares in a subsidiary ¥92,069 thousand / Extraordinary loss Loss on disposal and sale of non-current assets ¥4,697 thousand |
| Disclosure regarding the going concern assumption | Not applicable. |
| Change in accounting policy | Changes due to revisions to standards No / Other changes No / Change in accounting estimate No / Restatement No |
| Changes in the scope of consolidation | No material changes (none added or removed) |
| Material subsequent events | At a meeting of the Board of Directors held on 13 July 2026, the company resolved matters relating to the acquisition of treasury shares. |
| Availability of Supplementary Financial Results Materials | Yes |
| Availability of Financial Results Briefing | Available (for institutional investors and analysts) |
| Issued Shares at Period-End | 5,943,052 shares |
| Treasury Shares at Period-End | 14,632 shares |
| Factors Behind Changes in Business Performance | Revenue growth was driven by detergents, solid fuels and infection-control products. The increase in profit in the Chemicals business resulted from product sales, pricing and cost reductions, while labor and logistics costs weighed on profit. The Healthcare business reported lower revenue and profit due to declines in overseas and domestic product sales. |
Items this document does not state (3)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the current fiscal year, sales of detergents and solid fuels grew. On the profit side, expanded product sales in the Chemicals business, price revisions and cost reductions contributed to results. For the next fiscal year, the company expects the impact of higher raw material, labor and logistics costs, temporary cost increases associated with the expansion of regulated substances, and supply constraints.